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GlcN was administered alone or in combination with a CS-based gel
by a weekly intra-articular injection for 3 weeks. ECM organization was
assessed by histology.
Methods: Healthy and OA chondrocytes were isolated from the tibial
plateaus of human cadaveric articular cartilage, or from patients under-
going knee arthroplasty (NDRI, Philadelphia, USA). Cells were cultured
in chondrocyte medium (CM) for 2 passages, then photopolymerized
into 10% w/v PEGDA or 15% w/v PEGDA-RGD modiﬁed hydrogels.
Constructs were cultured for 1, 7, and 28 days in CM supplemented
with 0, 0.1, 1, and 2mM GlcN, or in chondrogenic medium (CM+) with
2mM GlcN. Cell viability was assessed by live-dead and DNA assays,
while tissue formation by histology, GAG, and collagen assays. Gene
analysis was performed by PCR. For in vivo studies, OA was induced
in rats by mechanical destabilization of the medial meniscus. Articular
cartilage changes were evaluated after 4 and 8 weeks to validate the
model. Two mM GlcN solutions in phosphate buffer saline (PBS) or in
CSMA-aldehyde gels were intra-articularly injected weekly for 3 weeks.
PBS was injected in control joints. Aggrecan synthesis was chosen as a
parameter to evaluate ECM regeneration and assessed by histology.
Results: OA cells were more susceptible to hydrogel encapsulation and
culture than healthy chondrocytes, as shown by viability data. RGD
motifs decreased cell mortality. Although donor dependent, histology and
GAG assays showed trends of increasing ECM formation with increasing
GlcN concentration. CM+ revealed a further chondrogenic enhancement
as compared to CM. PCR conﬁrmed the same trend for ECM related
markers. The inﬂammatory response (Il-1b and TNF-a) of OA cells
encapsulated in PEGDA decreased with increasing culturing time, while
it increased with increasing GlcN concentration. Conversely, the anti-
inﬂammatory response (Il-4) increased with increasing culture time and
GlcN concentration. RGD motifs induced an upregulation of Il-1b and
Il-4 over time and a downregulation with increasing GlcN concentration.
TNF-a did not signiﬁcantly change. Similar conclusions could be drawn
for healthy chondrocytes, with the exception of an upregulation of Il-4 with
increasing GlcN concentration.
From histological analysis, GlcN alone or in combination with CSMA-
aldehyde gel induced a signiﬁcant slow down of arthritic damage and
initial repair in rats that developed mild OA. Partial or minimal slow down
of OA and repair was induced at a late OA stage.
Conclusions: GlcN administration to OA chondrocytes enhanced cellular
ECM formation and modulated the inﬂammatory and anti-inﬂammatory re-
sponses in vitro. GlcN and GlcN-CSMA administrations initiated cartilage
regeneration in OA rats in vivo. GlcN could be a potential factor for mild
OA treatments and for the regeneration of cartilage in tissue engineering
applications.
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Purpose: Mesenchymal stem cells (MSCs) have the potential to dif-
ferentiate into cartilage, suggesting that the MSCs, especially those
close to the cartilage defects, are an important cell source for cartilage
regeneration. In the present study, we stimulated MSCs to differentiate
into the chondorcyte progenitors via trans-medullary approach using the
rabbit knees. Following the trans-medullary stimulation of MSCs, full-
thickness cartilage defects were created in order to investigate whether
the chondorcyte progenitors stimulated thereby could enhance the repair
of the full-thickness cartilage defects.
Methods: The animals were divided into 3 groups: In Group 1, full-
thickness articular cartilage defects (5mm in diameters; 5mm in depth)
were created in the patella groove of the femur. This group served as the
negative control. In Group 2, trans-medullary holes (2.5mm in diameter)
reaching to the immediate vicinity of the subchondral bone were created
4 days prior to the creation of cartilage defects. In Group 3, bFGF was
administered through the trans-medullary holes in order to augment the
stimulation of the MSCs. Other procedures followed those of the group 2.
The rabbits were sacriﬁced at 1, 2, 3, 4 and 8 weeks after the creation of
the osteochondral defects, and Bromodeoxyuridine (BrdU) positive cells
were enumerated and the histological grading score was counted.
Results: Enumerated BrdU positive cells indicated proliferation of the
cells was signiﬁcantly enhanced in Group 2 and 3 as compared with in
that of Group 1. The histological grading score of in Group 3 was superior
to the other groups and the score of the Group 1 remained the worst
throughout the studied periods.
Conclusions:We demonstrated that the in-advance stimulation of MSCs
via trans-medullary approach effectively increased the population of chon-
drocyte progenitors. The chondorcyte progenitors stimulated thereby are
likely to be recruited to the osteochondral defects at the appropriate time,
contributing to the repair of full-thickness articular cartilage defects.
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Purpose: Bioengineered cell constructs can be used in the treatment
of bone defects. Often Bone Marrow Stromal Cells (BMSCs) are used
that are in-vitro stimulated towards the osteogenic lineage aiming at
intramembranous bone formation. The success of this approach is disap-
pointing. A major concern in these constructs is core degradation, which
is caused by a lack of blood supply. We hypothesize that stimulation
of cells towards the endochondral ossiﬁcation process would be more
successful. In this study we test how in-vitro priming of human BMSCs
inﬂuences the endochondral ossiﬁcation process.
Methods: In vivo implantation: hBMSCs were seeded in collagen-
GAG scaffolds (3.0×105 per 8mm2). Seeded scaffolds were cultured
for 21 days on chondrogenic medium (n = 5) (DMEM-LG, TGF-beta2
10 ng/ml, Dexamethasone (Dex) 10−7 M, Ascorbic acid 25mg/ml, ITS) or
osteogenic medium (n = 4) (DMEM-HG, 10% FCS, Dex 10−7 M, Beta-
Glycerol-Phosphate (BGP) 10mM, Ascorbic acid 0.1mM) before they
were subcutaneously implanted at the back in nude mice. After 28 days
the scaffolds were obtained. Immunohistochemistry for Col-2 and Col-
10 and Von Kossa/Thionin staining, to observe mineralization and gly-
cosaminoglycan production, were performed.
In vitro pellet cultures: hBMSCs of three donors were obtained during
hip arthroplasty. 2.0 105 cells were cultured in pellets in 0.5ml of chon-
drogenic medium (as above). After 21 days of culture, when cartilage
was formed, the cultures were divided in three groups to be cultured for
another 14 days: group1 remained on chondrogenic medium; group 2
remained on chondrogenic medium and had BGP (10mM) added to
allow mineralization; in group 3 TGF-beta was removed from the medium,
BGP (10mM) was added and Dex was reduced to 10−8 M (osteogenic
medium). At day 7, 14, 21, 35 immunohistochemistry for Col-2 and Col-10
and Von Kossa/Thionin staining were performed. On the culture medium
of day 14, 21, 35 VEGFa production was determined by ELISA and gelatin
zymography for MMP-production was performed. For each analysis 3
pellets were used. All outcome measures were statistically evaluated
using mixed model analysis.
Results: In vivo implantation: Scaffolds that were pre-cultured on chon-
drogenic medium showed Col-2 and Col-10 production, but no miner-
alization. Moreover, vessels ingrowth that contained erythrocytes were
present. Pre-culturing with osteogenic medium induced mineralization,
but pycnotic cell nuclei were present and no Col-10 or vessel ingrowth
were observed.
In vitro pellet cultures: Pellets cultured in chondrogenic medium showed
progressive production of Col-2 and Col-10. In the medium of these
chondrogenic cultured pellets VEGF and MMPs were evidently present
at day 14, 21, 35. When pellets were switched to culture medium con-
taining BGP, independent of the presence of TGF-beta, huge regions of
mineralization were found. In the medium of these switched conditions
VEGF and MMP productions had severely diminished.
Conclusions: We demonstrated that in vivo implantation of in vitro
chondrogenically primed hBMSCs results in vessel invasion and Col-10
production, but not mineralization. By showing that VEGF and MMPs were
produced in chondrogenically differentiated hBMSCs we demonstrated
that these cells produce anabolic and catabolic factors that are known
to be important for the conversion of an avascularized to a vascularized
matrix. Inducing mineralization in this endochondral process does, how-
ever severely diminish these capacities. Altogether these results suggest
that chondrogenical priming of hBMSCs may improve vessel invasion in
bioengineered constructs, thereby optimizing its capacity to repair bone
defects.
